Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T68560 |
Totrombopag choline
|
||
Totrombopag, also known LGD-4665, GSK2285921 and SB559448, is an oral thromobopoietin receptor agonist, is being developed as a new generation small molecule thrombopoietin (TPO) mimetic. It is a highly selective and potent agonist of the TPO receptor and therefore induces differentiation and proliferation of megakaryocytes. The pharmacologic characteristics indicate potential therapeutic use in thrombocytopenic patients with a variety of clinical etiologies. | |||
T34905 |
Totrombopag
SB559448,SB 559448,SB-559448,LGD-4665,Synonym 2,LGD 4665,LGD4665 |
||
Totrombopag (SB559448) 是对RSV 聚合酶有作用的候选化合物。 |